RxDB
ICD-10-PCS Codes Browse (Tables)

ICD-10 PCS – Browse (Tables)

Code Title
– Top Categories
3 Administration
3E Physiological Systems and Anatomical Regions
3E0 Introduction Administration, Physiological Systems and Anatomical Regions, Introduction
3E06 Central Artery
3E063 Percutaneous
3E0630 Antineoplastic
3E06302 High-dose Interleukin-2 Introduction of High-dose Interleukin-2 into Central Artery, Percutaneous Approach
3E06303 Low-dose Interleukin-2 Introduction of Low-dose Interleukin-2 into Central Artery, Percutaneous Approach
3E06305 Other Antineoplastic Introduction of Other Antineoplastic into Central Artery, Percutaneous Approach
3E0630M Monoclonal Antibody Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Percutaneous Approach
3E0630P Clofarabine Introduction of Clofarabine into Central Artery, Percutaneous Approach
3E0631 Thrombolytic
3E06316 Recombinant Human-activated Protein C Introduction of Recombinant Human-activated Protein C into Central Artery, Percutaneous
3E06317 Other Thrombolytic Introduction of Other Thrombolytic into Central Artery, Percutaneous Approach
3E0632 Anti-infective
3E06328 Oxazolidinones Introduction of Oxazolidinones into Central Artery, Percutaneous Approach
3E06329 Other Anti-infective Introduction of Other Anti-infective into Central Artery, Percutaneous Approach
3E0633 Anti-inflammatory
3E0633Z No Qualifier Introduction of Anti-inflammatory into Central Artery, Percutaneous Approach
3E0634 Serum, Toxoid and Vaccine
3E0634Z No Qualifier Introduction of Serum, Toxoid and Vaccine into Central Artery, Percutaneous Approach
3E0636 Nutritional Substance
3E0636Z No Qualifier Introduction of Nutritional Substance into Central Artery, Percutaneous Approach
3E0637 Electrolytic and Water Balance Substance
3E0637Z No Qualifier Introduction of Electrolytic and Water Balance Substance into Central Artery, Percutaneous Approach
3E063F Intracirculatory Anesthetic
3E063FZ No Qualifier Introduction of Intracirculatory Anesthetic into Central Artery, Percutaneous Approach
3E063G Other Therapeutic Substance
3E063GC Other Substance Introduction of Other Therapeutic Substance into Central Artery, Percutaneous Approach
3E063GN Blood Brain Barrier Disruption Introduction of Blood Brain Barrier Disruption Substance into Central Artery, Percutaneous Approach
3E063H Radioactive Substance
3E063HZ No Qualifier Introduction of Radioactive Substance into Central Artery, Percutaneous Approach
3E063K Other Diagnostic Substance
3E063KZ No Qualifier Introduction of Other Diagnostic Substance into Central Artery, Percutaneous Approach
3E063N Analgesics, Hypnotics, Sedatives
3E063NZ No Qualifier Introduction of Analgesics, Hypnotics, Sedatives into Central Artery, Percutaneous Approach
3E063P Platelet Inhibitor
3E063PZ No Qualifier Introduction of Platelet Inhibitor into Central Artery, Percutaneous Approach
3E063R Antiarrhythmic
3E063RZ No Qualifier Introduction of Antiarrhythmic into Central Artery, Percutaneous Approach
3E063T Destructive Agent
3E063TZ No Qualifier Introduction of Destructive Agent into Central Artery, Percutaneous Approach
3E063V Hormone
3E063VG Insulin Introduction of Insulin into Central Artery, Percutaneous Approach
3E063VH Human B-type Natriuretic Peptide Introduction of Human B-type Natriuretic Peptide into Central Artery, Percutaneous Approach
3E063VJ Other Hormone Introduction of Other Hormone into Central Artery, Percutaneous Approach
3E063W Immunotherapeutic
3E063WK Immunostimulator Introduction of Immunostimulator into Central Artery, Percutaneous
3E063WL Immunosuppressive Introduction of Immunosuppressive into Central Artery, Percutaneous
3E063X Vasopressor
3E063XZ No Qualifier Introduction of Vasopressor into Central Artery, Percutaneous Approach